Aims and Scope
Journal of Pharmacovigilance-Open Access, goal of the journal is to publish high quality research with respect to the subject of pharmacovigilance, provide rapid a turnaround time for reviewing; publishing and freely disseminate drug safety and toxicity findings.
In today's wired world information is available at the click of a button, courtsey to the Internet. As an Open access publication the Journal of Pharmacovigilance has audience larger than that of any subscription-based journal. In addition to increasing the visibility and impact of published work due its Open Access formathe Journal of Pharmacovigilance -Open Access increases convenience, reach, and retrieval power while also providing barrier access to the research literature. Free online literature is available for software that facilitates full-text searching, indexing, mining, summarizing, translating, querying, linking, recommending, alerting, "mash-ups" and other forms data processing and analysis. Journal of Pharmacovigilance -Open Access puts rich and poor on an equal footing for these key resources and eliminates the need for permissions to reproduce and distribute content.
Longdom Publishing SL is committed to Open Access. We strongly believe that removing barriers to research published online will greatly aid to the progress in science and technical disciplines.
All Longdom Publishing SL published articles will be assigned DOI provided by CrossRef. The Journal of Pharmacovigilance will be kept upto date with the latest advances in the field. Papers published in the Journal of Pharmacovigilance will reach the readers directly by email for free of cost.
The Journal is archived online in the transactions of the Longdom Publishing SL, which provides the international scientific community with immediate and permanent access to individual papers.
Journal of Pharmacovigilance accepts online submission for case reports, original research, review articles, letters to the editors and brief comments that contribute to the previously published articles or other relevant findings in the field.
Open Access is a publication model that enables the dissemination of research articles to the global community without restriction usually through an internet. Thus, all articles published under Open Access can be accessed by anyone with internet connection. The Journal of Pharmacovigilance strongly supports the Open Access initiative. Abstracts and full texts (HTML, PDF and XML format) of all articles published by Journal of Pharmacovigilance are freely accessible to everyone immediately after publication.
All works published by Longdom Publishing SL are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited. Journal of Pharmacovigilance supports the Bethesda Statement on Open Access Publishing.
Definition of Open Access Publication
An Open Access Publication is one that meets the following two conditions:
- The author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.
- A complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable Open Access, unrestricted distribution, interoperability, and long-term archiving (for the biomedical sciences, PubMed Central is such a repository).
As a member of Publisher International linking Association, PILA, Journal of Pharmacovigilance (of Longdom Publishing SL) follows the Creative Commons Attribution License and Scholars Open Access publishing policies.
Community standards, rather than copyright law, will continue to provide the mechanism for enforcement of proper attribution and responsible use of the published work, as they do now.